Hannah M Cherniawsky (Hannah Cherniawsky)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Systematic Review

Chronic Lymphocytic Leukemia

Ejection Fraction

Top Venues

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Connor Frey, Hannah M Cherniawsky, Mahyar Etminan
Ocular adverse events following CAR-T cell therapy: A pharmacovigilance study and systematic review. European journal of haematology 113 (1) (2024)
Connor Frey, Hannah M Cherniawsky, Mahyar Etminan
Ocular adverse events following CAR-T cell therapy: A pharmacovigilance study and systematic review. European journal of haematology (2024)
Connor Frey, Hannah M Cherniawsky, Mahyar Etminan
Ocular adverse events following CAR-T cell therapy: A pharmacovigilance study and systematic review. European journal of haematology 113 (1) (2024)
Donna E Reece, Esther Masih-Khan, Ehetu G Atenafu, Victor H Jimenez-Zepeda, Arleigh McCurdy, Kevin Song, Richard LeBlanc, Michael Sebag, Darrell White, Hannah M Cherniawsky, Anthony Reiman, Julie Stakiw, Martha L Louzada, Rami Kotb, Muhammad Aslam, Engin Gul, Christopher P Venner
Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada. European journal of haematology 107 (4) (2021)
Hannah M Cherniawsky, Vishal Kukreti, Donna Reece, Esther Masih-Khan, Arleigh McCurdy, Victor H Jimenez-Zepeda, Michael Sebag, Kevin Song, Darrell White, Julie Stakiw, Richard LeBlanc, Anthony Reiman, Martha Louzada, Muhammad Aslam, Rami Kotb, Engin Gul, Eshetu Atenafu, Christopher P Venner
The impact of lenalidomide maintenance on second-line chemotherapy in transplant eligible patients with multiple myeloma. European journal of haematology 106 (5) (2021)